The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines.
from NDTV News - Special https://ift.tt/2EntxSq
Subscribe to:
Post Comments (Atom)
RIL profit rises 6% to Rs 22.6k crore in Q4
Reliance Industries reported a 6% rise in quarterly profit, reaching Rs 22,611 crore, driven by strong performances in its digital and retai...
-
Collecting Lego — yes, the plastic toys made of interlocking bricks that become cars and castles and robots —returned more than large stocks...
-
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News http://bit.ly/2VEK8DU...
-
A woman, in her early 20s, was stabbed to death by a man in southeast Delhi's Bhogal area on Friday evening, following which the accused...
No comments:
Post a Comment